Pfizer Recalls Bicillin L-A Injectable Antibiotic Due to Manufacturing Particulates
Pfizer is recalling Bicillin L-A (penicillin G benzathine) injectable antibiotic nationwide due to particulates identified during manufacturing quality inspections. The affected vials may contain visible foreign particles.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable drug with identified particulates—a risk-of-harm product. No illnesses or injuries have been reported in the source text. Score 3 applies per the rubric's criterion for risk-of-harm products where injury has not yet been reported.
Plain-English summary
Pfizer Inc. is recalling Bicillin L-A (penicillin G benzathine injectable suspension), a penicillin antibiotic used to treat bacterial infections. The recall affects approximately 50,855 vials nationwide, with doses of 1,200,000 units per 2 mL vial.
The recall is due to Current Good Manufacturing Practice (CGMP) deviations. Particulates have been identified during visual inspection of the affected vials. These foreign particles could pose a risk if injected.
The affected lot numbers are: HJ3235 (expiration 09/30/26), GL2954, HP6222 (expiration 01/31/27), HR9967 (expiration 05/31/27), HP6232, LT5190 (expiration 09/30/27), and HP6228 (expiration 10/31/27).
Healthcare providers should stop using the affected lots immediately and consult Pfizer or appropriate regulatory guidance regarding alternative treatments and proper disposal of unused product.
The recalled product
- Product
- BICILLIN L-A (PENICILLIN G BENZATHINE)
- Brand
- BICILLIN L-A
- Manufacturer
- Pfizer Inc.
- Category
- Drug — Injectable Antibiotic
- Hazard
- particulates
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- Lots: HJ3235
- Exp 09/30/26
- GL2954
- HP6222
- Exp
- 01/31/27
- HR9967
- Exp 05/31/27
- HP6232
- LT5190
- Exp 09/30/27
- HP6228
- Exp 10/31/27
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · BICILLIN L-A
- HighPfizer Bicillin L-A Injectable Suspension Recalled for Manufacturing Defects
FDA (Drugs) · 2025-08-06
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27